Long-term safety and disease control with Ruxolitinib cream in atopic dermatitis: Pooled results from two phase 3 studies

被引：0
|
作者：
Papp, K. [1 ]
Szepietowski, J. C. [2 ]
Kircik, L. [3 ]
Toth, D. [4 ]
Eichenfield, L. F. [5 ,6 ]
Forman, S. B. [7 ]
Kuligowski, M. E. [8 ]
Venturanza, M. E. [8 ]
Ren, H. [8 ]
Simpson, E. L. [9 ]
机构：
[1] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[2] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
[5] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA
[7] ForCare Clin Res, Tampa, FL USA
[8] Incyte Corp, Wilmington, NC USA
[9] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
94
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: pooled analysis of two phase III, randomized, double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E63
  • [22] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from two phase III randomized double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E116 - E117
  • [23] Efficacy of ruxolitinib cream in patients with atopic dermatitis who demonstrated partial responses: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB50 - AB50
  • [24] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Armstrong, April W.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB149 - AB149
  • [25] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan L.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Micahel E.
    Venturanza, May E.
    Wei, Shaoceng
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 651 - 653
  • [26] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Thaci, Diamant
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB160 - AB160
  • [27] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Leung, Donald Y. M.
    Forman, Seth B.
    Venturanza, May E.
    Sun, Kang
    Kuligowski, Michael E.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 863 - 872
  • [28] Effects of ruxolitinib cream on work productivity and activity impairment in patients with atopic dermatitis: 52-week pooled results from two phase III studies
    Eichenfield, Lawrence F.
    Augustin, Matthias
    Armstrong, April W.
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Silverberg, Jonathan I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E126 - E127
  • [29] Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
    Bloudek, Lisa
    Eichenfield, Lawrence F.
    Silverberg, Jonathan, I
    Joish, Vijay N.
    Lofland, Jennifer H.
    Sun, Kang
    Augustin, Matthias
    Migliaccio-Walle, Kristen
    Sullivan, Sean D.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (01) : 109 - 117
  • [30] Effects of ruxolitinib cream on patient-reported quality of life in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Armstrong, April W.
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E122 - E123
12345